The Yamanaka factors convert mouse embryonic fibroblasts (MEFs) into induced pluripotent stem cells (iPSCs) through a highly heterogeneous process. Here we profile single cells undergoing an optimized 7-day reprogramming process and show that cells start reprogramming relatively in sync, but diverge into two branches around day 2. The first branch of cells expressing Cd34/Fxyd5/Psca become nonpluripotent. The second one contains cells that are first Oct4+, then Dppa5a+ and pluripotent. We show that IFN-γ blocks this late transition. Our results reveal the heterogeneous nature of somatic cell reprogramming, identify Dppa5a as a marker for pluripotent and innate immunity as a potential barrier for reprogramming. One Sentence Summary: Single cell RNA sequencing reveals a continuum of cell fates from somatic to pluripotent and Dppa5a as a marker for chimera-competent iPSCs.
Introduction
Reprogramming of somatic cells to a pluripotent state represents a breakthrough for both regenerative medicine and biology (1) (2) (3) (4) (5) . For regenerative medicine, reprogramming enables the generation of patient-specific functional cells that can help cure diseases such as Parkinson's disease and spinal cord injury (6) (7) (8) (9) (10) (11) . For basic biology, reprogramming has provided valuable insight into how cell fate and cell fate transitions are regulated (12, 13) . By analyzing the cellular and molecular processes associated with reprogramming, it is clear that the process follows various states with distinct molecular signatures (14) (15) (16) (17) (18) (19) , that have been mapped by comprehensive transcriptomic, proteomic and epigenetic studies (16, 17, (20) (21) (22) (23) (24) (25) , generally only on bulk populations of cells. The analysis of bulk samples suggests MEFs are induced to a pluripotent state passing through several distinct biological processes, such as an early mesenchymal-epithelial transition, autophagy, histone and DNA demethylations (12, 19, (26) (27) (28) .
Despite progresses made through bulk analyses as outlined above, very little is known at the single cell level. The averaging of populations of cells tends to mask infrequent occurrences during reprogramming, thus obscure very rare essential cellular transitions, or overemphasize irrelevant biological processes not required for reprogramming. The fact that only a small fraction of the starting cells eventually become pluripotent demands a vigorous reappraisal of principles and mechanisms established by bulk analysis at single cell resolution (12, 29) . On the other hand, single cell analysis may be able to help us uncover rare but important mechanisms that have evaded so far (30) (31) (32) . In this report, we take advantage of an efficient and accelerated reprogramming system that converts MEFs to chimera competent iPSCs within seven days. By analyzing this reprogramming process at the single-cell resolution by RNA sequencing, we show a cell fate continuum bifurcating as early as day 2 towards either successful iPSC generation or alternative fates. Along this continuum, we have identified additional barriers at the very late phase of reprogramming, and also critical factors, particularly Dppa5a, that appear to govern the final transition to pluripotency. Further analysis at single-cell resolution will provide deeper insights into cell fate decisions that may be generally applicable to both biology and diseases.
Chimera competent pluripotent cells from OSK infected MEFs in 7 days
We take advantage of our previously described iCD1-OSK (OCT4, SOX2, KLF4) reprogramming system with MEFs carrying the OG2 (Oct4-GFP) reporter. This system results in around 10% of cells becoming iPSC colonies, and GFP+ cells begin to appear as early as day 3 (33) . However, as Oct4-GFP is not a marker for complete reprogramming, we decided to evaluate if any of the GFP+ cells are chimera competent. To this end, we infected MEFs with retrovirus expressing Oct4, Sox2 and Klf4 (OSK), and Oct4-GFP positive cells were isolated by FACS sorting, or picked-up at different days (See methods). These isolated GFP+ cells were injected into mouse blastocysts directly without culturing ( Fig. 1A ). This assay allows us to conclude that we can generate chimera competent cells around day 7 or 8 ( Fig. 1B , Table S1 and S2). The resulting chimeras indicated that day 7 GFP+ cells are chimera competent as 11.9% (7 out of 59) of live pups were chimeras ( Fig. 1 , B and C).
Single-cell RNA sequencing
After ascertaining chimera-competent iPSCs in this reprogramming system, we collected single cells with the C1 platform during reprogramming. In total, we isolated 1045 single cells at D0, D1, D2, D3, D5, D7, plus MEFs, iPSCs and ESCs (fig. S1A), and 901 of them passed quality control. We detected a median of 6889 genes and a minimum of at least 2982 genes in each cell ( fig. S1 , B to D). Pearson correlation between the mean expression for all cells at each time point to the bulk RNA-seq samples showed good correlation (R>0.8) (fig. S1E). We also estimated the infection efficiency of each exogenous transgenes by using reads from the RNA-seq that align cross the CDS and LTR ( fig. S2A ). We found that around 90% of the MEFs expressed all three exogenous transgenes, and the correlation between the expression level of the three transgenes was high ( fig. S2 , B and C). Projection of the RNAseq expression into a t-SNE space helped visualize the transitions as the cells reprogram ( Fig.  1D ). Compared to the tight clustering of single cells from MEFs and ESCs, the reprogramming cells are more scattered (Fig. 1D ). When key genes were mapped onto the t-SNE, it is clear that cells transition through distinct phases from Thy1+ to Nanog+ states in 7 days ( Fig. 1E ).
Reprogramming begin at near synchrony
Based on the projection in Figure 1D , it is apparent that cells at D0 and D1 are tightly clustered. Indeed, this is consistent with PCA analysis based on the top 3000 high variance genes among MEF, D0 and D1 ( Fig. 1F ). Plotting the gene contributions to PC1 and PC2 indicates that the left side of the PC1 loading represents mesenchymal-related genes, consistent with our earlier finding that reprogramming starts with a mesenchymal to epithelial transition (MET) (19) (fig. S2D ). Thy1 was reported before as a marker for cells resisting to reprogramming (16) , but it was almost completely silenced in our system at D1 (Fig. 1 , E and G, and fig. S2E ). Interestingly, the right side of the PC1 loading represents genes critical for metabolism ( fig. S2D ), suggesting that cells at D1 are leaving the mesenchymal state and reaching a metabolically active intermediate state. We further confirmed the well-defined MET process, which should serve as a validation assay for our single cell data ( Fig. 1G and fig. S2F ). Furthermore, consistent with previous report that cell surface markers such as CD73, CD104/CD49d are expressed by intermediate reprogramming prone cells (34), we show that Nt5e (coding for CD73) and Itgb4 (coding for CD104) are upregulated in most of cells by day 2, and Itga4 (coding for CD49d) at day 1 (fig. S3A ). The upregulation of Itgb4 is positively correlated to an early epithelial program, as measured by the co-expression of the epithelial cadherin Cdh1 ( fig. S3 , B and C). Additionally, although Itg4b is only expressed briefly at day 1, we show that CD104+ cells are biased towards successful reprogramming ( fig. S3 , D and E).
Reprogramming cells bifurcate early into reprogramming vs non-reprogramming cells
In order to understand the fate trajectories of cells undergoing reprogramming, we combined pathway and gene set over dispersion analysis (PAGODA) (35) with diffusion mapping analysis (36) . As shown in Figure 2A , two fate branches emerged. By loading the 519 differentially expressed genes between them on a heatmap, we show that one branch is likely to represent reprogramming fate (R, downward) as these cells express mostly pluripotent genes such as Tet2, Sall4, and Dppa5a, while the second branch represent the nonreprogramming (NR, upward) fate in which cells express Fxyd5, Psca an Cd34 ( Fig. 2A, 2B ). When we mapped specific genes to the diffusion map, it is clear that while Cdh1 appears to be present in both NR and R cells, Cd34, Fxyd5 and Psca with the NR, Sall4 and Dppa5a with R ( Fig. 2C ). We also analyzed the cellular trajectories using monocle2 (37, 38) , which also generated two branches (NR' and R', respectively) that are highly similar to the NR/R branches described above ( fig. S4 , A to E). One explanation for the differences between R and NR fates could be the differential expression of reprogramming factors from viraldelivered transgenes. However, we found no correlation between the expression levels of exogenous transgenes and R/NR fates (fig. S5, A and B). In fact, NR cells express similar levels of OSK as R cells ( Fig. S5A ), suggesting that the bifurcation into R and NR is not due to the absence of OSK infection in the NR cells.
Given the fact that genes such as Psca and CD34 clearly mark the NR and NR' identified in both methods (Fig. 2B, Fig. S4B and S4E), we decided to take advantage of the fact that CD34 being a well-known cell surface marker to show that CD34+ cells do not overlap with Oct4-GFP positive cells at D7 ( fig. S5C ). To see if CD34 can denote the bifurcation at early time point, we sorted D3 cells into CD34+ and CD34-population and replanted them for further reprogramming (Fig. 2D and fig. S5D ). As shown in Figure 2D , when scored as Oct4-GFP positive colonies at D7, we show that the CD34+ cells are 10 times less efficient than the CD34-ones to give rise to GFP+ iPSCs, indicating that CD34 marks cells for the NR branch. Flow cytometry analysis of further reprogramming cells at D7 also showed that most of the CD34+ population at D3 remained CD34+ cells, and hardly acquired Oct4-GFP, whilst CD34-cells rarely gained CD34 expression, indicating that CD34 cells are committed to an NR fate ( fig. S5D ). We then randomly picked Oct4-GFP+ and GFP-colonies at day 9 and performed RNA-seq on them. We found that the Oct4-GFP negative colonies express gene set from non-pluripotency lineages, indicating that they have reached a stable alternative fate during reprogramming process ( fig. S5E ).
Approaching pluripotency
A significant portion of the R cells also fail to reach pluripotency based on the scattered nature of the D7 cells in Figure 1D . To further deconstruct the fate of these cells, we revisited Figure 1D and identified 5 single cells that appear to have committed to pluripotency ( Fig 1E,  3A and fig. S6A ). These 5 cells are very closely related to the the ESC group, and expressing a series of pluripotent genes such as Dppa5a, Tdgf1 and Utf1 (fig. S6B ). Indeed, when we clustered the D7 cells into 6 groups with an unsupervised SNN-Cliq method (39) (Fig. 3B) , we could independently identify these 5 cells shown in Figure 3A from the rest. The five pluripotent cell (PC) candidates show a strong similarity to ESCs in a co-correlation heatmap analyzed by SC3 (REF) (Fig. 3C ), suggesting that these cells may be the ones capable of contributing to chimeras as demonstrated in Figure 1B . Indeed, the expression patterns of critical pluripotency genes in D5, D7, and D7-committed cells and ESCs confirm their close relationship to ESCs (Fig. 3D ). By qPCR analysis of select genes, we show that they are indeed exclusively expressed in day 7 cultures ( fig. S6C ). We also examined several published RNA-seq or microarray datasets of the reprogramming processes and found that these 'PC candidates trait' genes are expressed at very low, or undetectable level until the very last reprogramming timepoints, suggesting that these genes could serve as markers for very late stage pluripotency and chimera competency ( fig. S6D ).
Dppa5a as a key marker for chimera competent fate
Based on the heterogeneity of D7 cells, we then attempted to isolate the cluster 6 cells which may represent the final stage of reprogramming and chimera competency for iPSCs. Given its high level of expression in the PC candidates, ESCs, and iPSCs, Dppa5a appears to be a strong candidate for a new marker to identify these chimera competent iPSCs. To test this idea, we generated a Dppa5a-tdTomato reporter in the OG2 background. We show that colonies at D7 can be identified as Oct4-GFP+ and Dppa5a-tdTomato+ double positive (G+R+) (Fig. 4A ). We further show by FACS analysis of cells at D7 and D8 that Dppa5a-tdTomato positive cells can emerge only from the Oct4-GFP positive cells (Fig. 4B ). We stained the D7 cells with NANOG antibody and showed that Dppa5a-tdTomato colonies were emerged from the NANOG positive colonies ( fig. S6E ). To confirm that G+R+ cells are responsible for the live chimeras, we then performed chimera assay again by picking G+R+ or G+R-colonies at D7.5, and injected them into blastocysts. We showed that the G+R+ cells are capable, but G+R-not, of giving rise to live chimeras (Fig. 4 , C and D, and Table  S2 ). Taken together, these results support the idea that the cluster 6 PC candidates defined by single-cell analysis are the ones chimera competent as shown in Figure 1 .
Immune response at the mid to late stage of reprogramming.
In addition to discovering late stage markers, we also observed many transient intermediate stages, as has other groups (15, 34, 40) . These transient stages may be genuine cell state traversals, but may also be barriers to reprogramming. To identify potential barriers preventing the generation of chimera competent iPSCs, we compared specific genes up-or down-regulated between PC candidates vs the rest of the D7 cells (Fig. 5A) . Surprisingly the genes most associated with the rest of the D7 cells are related to immune response, and specifically an interferon-gamma response (Fig. 5B) . To confirm this, we re-analyzed gene expression from the single cell sequencing, and identified one of the clusters as being primarily immune response genes specifically activated in the middle to late stages of reprogramming (D2 to D7), but silenced at the end stage of reprogramming and in ESCs (Fig.  5 , A, C-F, and fig. S7A ).
IFN-γ impedes the transition to iPSCs
To understand what is causing this immune response we performed ELISA assays on serum free media collected during reprogramming. As shown in Figure 6A , IFN-γ starts to rise at D3 and peaks at D4 and D5, then declines around D7, consistent with the single cell sequencing and qPCR data (Fig. 5, C and D, and fig. S7 , A and C). Consistently, we did not observe any appreciable activation of IFN-β ( fig. S7B ). To see if IFN-γ influences cell fate decision during reprogramming, we added IFN-γ and IFN-β to reprogramming cells. We show that the two cytokines activate different immune response genes (41) (Fig. 6B ), but critically, only IFNγ can suppress the expression of late-stage genes, such as Dppa5a (Fig.  6C) . We further show that IFN-γ completely blocked the formation of Dppa5a-Tdtomato positive clones, but only has a limited impact on the formation of Oct4-GFP+ colonies (Fig.  6D) . Interestingly, we tried to block IFN-γ with anti-IFN-γ antibodies and show that while the antibodies do not enhance Oct4-GFP+ colonies, but nevertheless enhance the expression of late reprogramming markers such as Dppa5a and Ooep (Fig. 6E) . However, these genes failed to be up-regulated by antibodies for IFNAR1 (one of the receptor of IFN-β) ( fig. S7 , D to F), indicating IFN-γ, but not IFN-β, is a barrier for the very late stage of reprogramming we have identified here, marked by Dppa5a expression. We also re-analyzed the CD34+ lineage to see if it was responsible for the production of IFN-γ, however, found no such evidence ( fig. S7G ). These results demonstrate that type-II interferon can act as a barrier to final step of reprogramming.
Discussion
In this study, by performing single cell RNA sequencing, we have resolved cell fate transitions during somatic reprogramming. We demonstrate that cells branch into two distinct fates early and CD34 denotes this critical bifurcation to pluripotent or non-pluripotent fates. Towards the pluripotent fate, we identified a late rate-limiting step regulated by IFN-γ and Dppa5a as a reliable marker for chimera competent iPSCs.
These mechanistic understandings have evaded previous investigation, thus, demonstrating the power of single cell RNA sequencing.
Unlike cells collected in tissue or during development process, cells undergoing somatic reprogramming, which is an artificial process induced by overexpression of transgenes, would render their heterogeneity with more subtle change. As shown in Figure 1D , the reprogramming cells at D2-D7 were scattered and hard to been divided into different cell populations. Another challenge is to confirm the physiology function of cell sub-populations which were defined based on transcriptome data analysis. We set the analyzed results as hypothesizes and proved them experimentally. For example, we defined the "PC candidates" and sorted these cells sub-population with knock-in reporter, then injected them into blastocysts and finally established its chimera-competent function in vivo. This strategy assured we got solid understanding about cell heterogeneity during somatic reprogramming.
We and others have argued previously that reprogramming represents one of the best systems to study cell fate conversion mechanistically. Since reprogramming represents cell fate transitions from a fully differentiated cell to a fully pluripotent one, thus, displaying the whole spectrum of possibilities between somatic and pluripotent fates, any mechanism uncovered may become useful and relevant to biology. Our finding that IFN-γ impedes the last transition to pluripotency suggests that stem cell fate and immune responses are interconnected. Indeed, it is interesting to point out that earlier reports have identified components of innate immune response activated by the reprogramming factors or viral infection as a positive event required for the acquisition of pluripotency. For example, tolllike receptor 3 (TLR3) have been shown to be required for reprogramming (42) , and interleukin-6 (IL-6) can facilitate reprogramming (43) . It is plausible that innate immunity influences cell fate differentially through individual components such as TLR3, IL6 and IFNγ . For example, IFN-γ may block the activation of endogenous retroviral elements or other transposable elements so that it prevents the activation of the pluripotent state (44) . It is expected that more mechanistic insights can be generated that may inform us on how to improve reprogramming technologies.
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